Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET.
Here's a recap of Friday's key moments. 1. Wall Street was bouncing higher Friday after, as Jim Cramer put it, a "really bad day" in the prior session.
Thursday's late-day decline happened as bond yields rose on "good economic data being viewed as bad news." The market also sold off despite a 9% post-earnings increase in shares of Nvidia . The AI chip giant's stock was up modestly Friday.
Goldman Sachs pushed its forecast for the first Federal Reserve interest rate cut to September from July. Rates must remain higher for longer because we "can't have inflation being the biggest problem in America," Cramer said Friday. 2.
Eli Lilly is investing $5.3 billion to boost manufacturing at an Indiana plant to expand production of weight loss drug Zepbound, diabetes treatment Mounjaro, and others. That brings Lilly's total investment at the site to $9 billion from $3.
7 billion. The company expects to begin making medicines at the site toward the end of 2026, with operations scaling up through 2028. That big investment upfront shows Lilly's commitment.
"There's such demand for this product," Cramer said, referring to those GLP-1s with the common active ingredient tirzepatide. Zepbound and Mounjaro compete against Novo Nordisk 's Wegovy and Ozempic. 3.
Four Club names report earnings next week: Salesforce, Best Buy, Foot Locker and Costco. Salesforce is on Wednesday after the clo.
